Diagnostic Radiology/Musculoskeletal Imaging/Tumors Basic/Giant cell tumor

From Wikibooks, open books for an open world
< Diagnostic Radiology‎ | Musculoskeletal Imaging‎ | Tumors Basic
Jump to: navigation, search

Giant cell tumors of the bone are uncommon bone tumors which represent around 4-5% of primary bone tumors and 18% of all benign bone lesions. They are interesting in the fact that their classic radiographic appearance is easily identifiable.

Giant cell tumors can either be benign or malignant, although the majority of them are benign. Radiographically, benign versus malignant tumors are difficult to distinguish. In most patients, the tumor has an indolent course, but repeated local recurrence of the tumor does happen. Approximately 5% of giant cell tumors are defined as malignant. Malignancy usually occurs as the result of malignant transformation after radiation therapy.

These tumors are slightly more common in females, with 50-57% of cases occurring in females. The general age range for giant cell tumors is 20-40 years old. Approximately 85% of tumors occur in the long bones, namely the distal femur, proximal tibia, proximal humerus, and distal radius. Another location typical of giant cell tumor is the spine, particularly the sacrum. Spinal involvement is typically in the vertebral body, although its location is variable.

Clinical presentation is nonspecific, and it usually is pain at the tumor site. Pathologic fracture occurs around 10% of the time. Local mass effect can cause a range of symptoms, for example, from posterior expansion into the spinal canal.

Radiology[edit]

AP View Lateral View


Spinal involvement is less specific, and vertebral body destruction and collapse can be identified. As described above, the most common location for giant cell tumor is in the vertebral body.

CT: Imaging findings are similar to that of the plain film.

MRI: Heterogeneous low-to-intermediate T1 and T2 signal for the solid portions of the tumor. Hemosiderin can be seen in 60% of the tumors. Cystic areas are of the typical high T2 signal, and fluid levels can be identified within the tumor. As is typical for MRI, it is helpful in determining the extent and local involvement of the tumor.

Bone scan: Homogeneous uniform uptake, nonspecific.

Treatment[edit]

Typical treatment for giant cell tumors is curettage and packing of the lesions. The main complication is local recurrence.

References[edit]

Giant Cell Tumor by Eddie Lee, M.D., University of Washington, Department of Radiology

Dahlin, David C. Bone Tumors. Second edition. (1967). p. 78-88.

Danhert, Wolfgang. Radiology Review Manual. Third edition. (1996). p.64.

Resnick, et al. Diagnosis of Bone and Joint Disorders. Second edition. (1988). Volume 6. p. 3787-3806.

Weissleder, et al. The Primer of Diagnostic Imaging. Third edition. (2003). p. 432.